Shenzhen-based AI-driven longevity biotech developing cross-species aging models and anti-aging drug candidates
Shenzhen-based AI-driven longevity biotech developing cross-species aging models and anti-aging drug candidates. Its Longevity Foundation Model analyzes single-cell and multi-omics data to identify aging targets and therapeutic combinations. The company is pursuing pet therapeutics as a faster route to proof of concept and data generation, with potential translation to human longevity drugs.